07.01.2013 Views

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

TRICY<br />

500509<br />

bronchospasm) in infants and children less than 5 years due to food sensitivity (milk, egg, soy, and wheat<br />

proteins) followed by respiratory disease (rhinitis and asthma) in older children and adults due to<br />

sensitivity to inhalant allergens (dust mite, mold, and pollen inhalants).<br />

Useful For: <strong>Test</strong>ing for IgE antibodies may be useful to establish the diagnosis of an allergic disease<br />

and to define the allergens responsible for eliciting signs and symptoms. <strong>Test</strong>ing also may be useful to<br />

identify allergens which may be responsible for allergic disease and/or anaphylactic episode, to confirm<br />

sensitization to particular allergens prior to beginning immunotherapy, and to investigate the specificity of<br />

allergic reactions to insect venom allergens, drugs, or chemical allergens.<br />

Interpretation: Detection of IgE antibodies in serum (Class 1 or greater) indicates an increased<br />

likelihood of allergic disease as opposed to other etiologies and defines the allergens that may be<br />

responsible for eliciting signs and symptoms. The level of IgE antibodies in serum varies directly with the<br />

concentration of IgE antibodies expressed as a class score or kU/L.<br />

Reference Values:<br />

Class IgE kU/L Interpretation<br />

0 Negative<br />

1 0.35-0.69 Equivocal<br />

2 0.70-3.49 Positive<br />

3 3.50-17.4 Positive<br />

4 17.5-49.9 Strongly positive<br />

5 50.0-99.9 Strongly positive<br />

6 > or =100 Strongly positive Reference values<br />

apply to all ages.<br />

Clinical References: Homburger HA: Allergic diseases. In Clinical Diagnosis and Management by<br />

Laboratory Methods. 21st edition. Edited by RA McPherson, MR Pincus. New York, WB Saunders<br />

Company, 2007, Chapter 53, Part VI, pp 961-971<br />

Tricyclic Antidepressant Screen, Serum<br />

Clinical Information: Amitriptyline Amitriptyline is a tricyclic antidepressant (TCA) that is<br />

metabolized to nortriptyline, which has similar pharmacologic activity. The relative blood levels of<br />

amitriptyline and nortriptyline are highly variable among patients. Amitriptyline is the drug of choice in<br />

treatment of depression when the side effect of mild sedation is desirable. Nortriptyline is used when its<br />

stimulatory side effect is considered to be of clinical advantage. Amitriptyline displays major cardiac<br />

toxicity when the concentration of amitriptyline and nortriptyline is in excess of 300 ng/mL, characterized<br />

by QRS widening leading to ventricular tachycardia and asystole. In some patients, toxicity may manifest<br />

at lower concentrations. Nortriptyline Nortriptyline is unique among the antidepressants in that its blood<br />

level exhibits the classical therapeutic window effect; blood concentrations above or below the therapeutic<br />

window correlate with poor clinical response. Thus, therapeutic monitoring to ensure that the blood level<br />

is within the therapeutic window is critical to accomplish successful treatment with this drug.<br />

Nortriptyline is a TCA used for treatment of endogenous depression. It also is a metabolite of the<br />

antidepressant amitriptyline. Nortriptyline is used when its stimulatory side effect is considered to be of<br />

clinical advantage; amitriptyline is used when the side effect of mild sedation is desirable. Like<br />

amitriptyline, nortriptyline can cause major cardiac toxicity when the concentration is in excess of 300<br />

ng/mL, characterized by QRS widening leading to ventricular tachycardia and asystole. In some patients,<br />

toxicity may manifest at lower concentrations. Imipramine Imipramine and its metabolite desipramine are<br />

TCAs used to treat endogenous depression requiring 1 to 3 weeks of treatment before therapeutic<br />

effectiveness becomes apparent. Desipramine is used for treatment of endogenous depression when the<br />

patient needs a drug with significant stimulatory side effects. These drugs have also been employed in the<br />

treatment of enuresis (involuntary urination) in childhood and severe obsessive-compulsive neurosis. The<br />

Current as of January 4, 2013 7:15 pm CST 800-533-1710 or 507-266-5700 or <strong>Mayo</strong><strong>Medical</strong><strong>Laboratories</strong>.com Page 1788

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!